CymitQuimica logo

CAS 75970-64-8

:

1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-4-piperidinyl-, hydrobromide (1:2)

Description:
1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-4-piperidinyl-, hydrobromide (1:2) is a chemical compound characterized by its complex structure, which includes a benzimidazole core, a piperidine moiety, and a fluorophenyl group. This compound typically appears as a crystalline solid and is soluble in polar solvents, reflecting its ionic hydrobromide form. The presence of the piperidine ring contributes to its potential biological activity, often associated with pharmacological properties. The fluorophenyl substituent may enhance lipophilicity and influence the compound's interaction with biological targets. As a hydrobromide salt, it is often more stable and easier to handle than its free base form. This compound is of interest in medicinal chemistry, particularly for its potential applications in drug development, where modifications to the benzimidazole structure can lead to varied biological activities. Safety and handling precautions should be observed, as with all chemical substances, due to potential toxicity and reactivity.
Formula:C19H21FN4·2BrH
InChI:InChI=1S/C19H21FN4.2BrH/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16;;/h1-8,16,21H,9-13H2,(H,22,23);2*1H
InChI key:InChIKey=IVXYTQSEWOVUDL-UHFFFAOYSA-N
SMILES:C(N1C=2C(N=C1NC3CCNCC3)=CC=CC2)C4=CC=C(F)C=C4.Br
Synonyms:
  • 1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-4-piperidinyl-, hydrobromide (1:2)
  • 1-(4-Fluorobenzyl)-N-piperidin-4-yl-1H-benzimidazol-2-amine dihydrobromide
  • Norastemizole hydrobromide
  • 1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-4-piperidinyl-, dihydrobromide
  • R 41232
Sort by

The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
  • Norastemizole Hydrobromide

    Controlled Product
    CAS:

    Applications An antihistamine used to treat allergic rhinitis and asthma which does not induce adverse effects such as cardiac arrhythmia, fatigue, or general body weakness.
    References Janssens, F., et al.: J. Med. Chem., 28, 1934 (1985),

    Formula:C19H23Br2FN4
    Color and Shape:Neat
    Molecular weight:486.22

    Ref: TR-N661060

    25mg
    227.00€
    50mg
    313.00€
    100mg
    554.00€